We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DNA market cap is 460.21M. The company's latest EPS is USD -9.4261 and P/E is -0.83.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 34.76M | 37.94M | 56.21M | 89.05M | 43.85M |
| Operating Income | -179.24M | -178M | -222.95M | -55.2M | -98.78M |
| Net Income | -211.69M | -165.91M | -217.18M | -56.4M | -107.53M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 313.84M | 477.71M | 251.46M | 227.04M |
| Operating Income | -5k | -1.91B | -2.25B | -770.83M | -554.93M |
| Net Income | -5k | -1.83B | -2.1B | -892.87M | -547.03M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.67B | 1.58B | 1.63B | 1.48B | 1.38B |
| Total Liabilities | 568.19M | 594.49M | 792.18M | 682.94M | 661.39M |
| Total Equity | 1.1B | 987.27M | 833.07M | 797.94M | 716.06M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.25M | 2.07B | 2.54B | 1.67B | 1.38B |
| Total Liabilities | 1.23M | 503.61M | 803.04M | 568.19M | 661.39M |
| Total Equity | 20k | 1.57B | 1.74B | 1.1B | 716.06M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -295.5M | -89.26M | -173.65M | -277.15M | -319.59M |
| Investing | -80.69M | -12.11M | -38.95M | -49.15M | -62.24M |
| Financing | -3.22M | -845k | -1.07M | -1.54M | -1.74M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -253.82M | -252.2M | -295.5M | -319.59M |
| Investing | N/A | -73.26M | -67.39M | -80.69M | -62.24M |
| Financing | N/A | 1.53B | 95.34M | -3.22M | -1.74M |
| Market Cap | 460.21M |
| Price to Earnings Ratio | -0.83 |
| Price to Sales Ratio | 2.01 |
| Price to Cash Ratio | 0.81 |
| Price to Book Ratio | 0.64 |
| Dividend Yield | - |
| Shares Outstanding | 58.03M |
| Average Volume (1 week) | 1.19M |
| Average Volume (1 Month) | 1.57M |
| 52 Week Change | -75.85% |
| 52 Week High | 45.20 |
| 52 Week Low | 5.00 |
| Spread (Intraday) | 0.22 (2.75%) |
| Company Name | Ginkgo Bioworks Holdings Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ginkgobioworks.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
